The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome

Clinical Endocrinology

Volumn 77, Issue 6, 2012, Pages 885-892

  Kaya, Mehmet G ^a   Calapkorur, Bekir ^a   Karaca, Zuleyha ^a   Yildirim, Sumeyra ^a   Celik, Ahmet ^a   Akpek, Mahmut ^a   Unluhizarci, Kursad ^a   Kelestimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; GLUCOSE; INSULIN; METFORMIN;

ADULT; AORTA; AORTA VALVE REGURGITATION; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LABORATORY TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TREATMENT DURATION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANDROSTENES; AORTA; BODY MASS INDEX; DRUG THERAPY, COMBINATION; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME; VASCULAR STIFFNESS; WEIGHT LOSS;

EID: 84869020356     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04436.x     Document Type: Article

References (42)

1. Norman, R.J., Dewailly, D., Legro, R.S., et al,. (2007) Polycystic ovary syndrome. Lancet, 370, 685-697. (Pubitemid 47285318)
2. Legro, R.S., Finegood, D., &, Dunaif, A., (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 83, 2694-2698. (Pubitemid 28493762)
3. Ehrmann, D.A., (2005) Polycystic ovary syndrome. The New England Journal of Medicine, 352, 1223-1236.
4. Kaya, M.G., Gunebakmaz, O., Zencir, C., et al,. (2010) An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome. Fertility and Sterility, 94, 2402-2405.
5. Carmina, E., (2009) Cardiovascular risk and events in polycystic ovary syndrome. Climacteric: The Journal of the International Menopause Society, 12 (Suppl 1), 22-25.
6. Dessapt-Baradez, C., Reza, M., Sivakumar, G., et al,. (2011) Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome. PLoS One, 6, e20317.
7. Webb, D.R., Khunti, K., Silverman, R., et al,. (2010) Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia, 53, 1190-1198.
8. Park, J.S., Nam, J.S., Cho, M.H., et al,. (2010) Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women. Menopause, 17, 779-784.
9. Cruickshank, K., Riste, L., Anderson, S.G., et al,. (2002) Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation, 106, 2085-2090. (Pubitemid 35192814)
10. Tavil, Y., Ozturk, M.A., Sen, N., et al,. (2008) The assessment of cardiac functions by tissue Doppler-derived myocardial performance index in patients with Behcet's disease. Clinical Rheumatology, 27, 309-314.
11. Vrbikova, J., &, Cibula, D., (2005) Combined oral contraceptives in the treatment of polycystic ovary syndrome. Human Reproduction Update, 11, 277-291. (Pubitemid 40668112)
12. Diamanti-Kandarakis, E., Baillargeon, J.P., Iuorno, M.J., et al,. (2003) A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. The Journal of Clinical Endocrinology and Metabolism, 88, 1927-1932. (Pubitemid 36549858)
13. Yildiz, B.O., (2008) Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment. Seminars in Reproductive Medicine, 26, 111-120.
14. Hickson, S.S., Miles, K.L., McDonnell, B.J., et al,. ENIGMA Study Investigators. (2011) Use of the oral contraceptive pill is associated with increased large artery stiffness in young women: the ENIGMA study. Journal of Hypertension, 29, 1155-1159.
15. Diamanti-Kandarakis, E., Alexandraki, K., Protogerou, A., et al,. (2005) Metformin administration improves endothelial function in women with polycystic ovary syndrome. European Journal of Endocrinology, 152, 749-756. (Pubitemid 40744544)
16. Agarwal, N., Rice, S.P., Bolusani, H., et al,. (2010) Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. The Journal of Clinical Endocrinology and Metabolism, 95, 722-730.
17. Mathur, R., Alexander, C.J., Yano, J., et al,. (2008) Use of metformin in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology, 199, 596-609.
18. Azziz, R., Carmina, E., Dewailly, D., et al,. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility, 91, 456-488.
19. Professional Practice Committee, American Diabetes Association. (2004) Clinical practice recommendations. Diabetes Care, 27, S5-S10.
20. Bonora, E., Targher, G., Alberiche, M., et al,. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care, 23, 57-63.
21. Henry, W.L., DeMaria, A., Gramiak, R., et al,. (1980) Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography Circulation, 62, 212-217. (Pubitemid 10035638)
22. Kaya, M.G., Ozdogru, I., Inanc, T., et al,. (2007) Aortic stiffness formula. American Journal of Hypertension, 20, 816. (Pubitemid 46936173)
23. Cibula, D., Fanta, M., Vrbikova, J., et al,. (2005) The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenemia, SHBG and lipids in PCOS patients. Human Reproduction, 20, 180-184.
24. Elter, K., Imir, G., &, Durmusoglu, F., (2002) Clinical, endocrine and metabolic effects of metformin added to ethinyl-estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Human Reproduction, 17, 1729-1737. (Pubitemid 34790292)
25. Franks, S., (2011) When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clinical Endocrinology (Oxford), 74, 148-151.
26. Palombo, S., Falbo, A., Zullo, F., et al,. (2009) Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocrine Reviews, 30, 1-50.
27. Pasquali, R., &, Gambineri, A., (2006) Insulin-sensitizing agents in women with polycystic ovary syndrome. Fertility and Sterility, 86 (Suppl 1), S28-S29.
28. Topcu, S., Tok, D., Caliskan, M., et al,. (2006) Metformin therapy improves coronary microvascular functions in patients with polycystic ovary syndrome and insulin resistance. Clinical Endocrinology (Oxford), 65, 75-80.
29. Bellot-Rojas, P., Posadas-Sanchez, R., Caracas-Portilla, N., et al,. (2006) Comparison of metformin versus rosiglitazone in patients with acanthosis nigricans: a pilot study. Journal Of Drugs In Dermatology, 5, 884-889.
30. Hess, A.M., &, Sullivan, D.L., (2004) Metformin for prevention of type 2 diabetes. The Annals of Pharmacotherapy, 38, 1283-1285. (Pubitemid 38802176)
31. Diamanti-Kandarakis, E., Alexandraki, K., Piperi, C., et al,. (2007) Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental, 56, 129-134. (Pubitemid 44855021)
32. Helvaci, M.R., Sevinc, A., Camci, C., et al,. (2008) Treatment of white coat hypertension with metformin. International Heart Journal, 49, 671-679.
33. Calvert, J.W., Gundewar, S., Jha, S., et al,. (2008) Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes, 57, 696-705.
34. Sasaki, H., Asanuma, H., Fujita, M., et al,. (2009) Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation, 119, 2568-2577.
35. Diamanti-Kandarakis, E., Christakou, C.D., Kandaraki, E., et al,. (2010) Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. European Journal of Endocrinology, 162, 193-212.
36. Iannuzzi, A., Rubba, P., Pauciullo, P., et al,. (1999) Stiffness of the aortic wall in hypercholesterolemic children. Metabolism: Clinical and Experimental, 48, 55-59. (Pubitemid 29035561)
37. Tomiyama, H., Hirayama, Y., Hashimoto, H., et al,. (2006) The effects of changes in the metabolic syndrome detection status on arterial stiffening: a prospective study. Hypertension Research: Official Journal of Japanese Society of Hypertension, 29, 673-678. (Pubitemid 44605365)
38. Creatsa, M., Armeni, E., Stamatelopoulos, K., et al,. (2012) Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism: Clinical and Experimental, 61, 193-201.
39. Miyaki, A., Maeda, S., Yoshizawa, M., et al,. (2009) Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men. Angiology, 60, 351-357.
40. Izzo Jr, J.L., (2004) Arterial stiffness and the systolic hypertension syndrome. Current Opinion in Cardiology, 19, 341-352. (Pubitemid 38916492)
41. Creatsas, G., Koliopoulos, C., &, Koltsidopoulos, A., (2000) Combined oral contraceptive treatmentof adolescent girls with polycystic ovary syndrome. Lipid profile. Annals of The New York Academy of Science, 900, 245-252. (Pubitemid 30251475)
42. Christakou, C.D., &, Diamanti-Kandarakis, E., (2008) Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Women's Health (London, England), 4, 583-594.